{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T06:55:20Z","timestamp":1769324120375,"version":"3.49.0"},"reference-count":9,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Sage Open Medical Case Reports"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>Dasatinib is an effective agent in the treatment of bcr-abl positive acute lymphoblastic leukemia and chronic myeloid leukemia cases. Various skin reactions may occur when tyrosine kinase inhibitors are used. The severity of side effects increases in phototoxic reactions with sunlight. In this case, a phototoxic rash that developed in a 78-year-old bcr-abl positive acute lymphoblastic leukemia patient is presented. This case supports that phototoxic reactions may occur with dasatinib and emphasizes that clinicians should be alert for this side effect.<\/jats:p>","DOI":"10.1177\/2050313x251330969","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T02:09:10Z","timestamp":1742954950000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Periorbital edema and phototoxic rash associated with dasatinib: A case report"],"prefix":"10.1177","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4109-7617","authenticated-orcid":false,"given":"Bera Omer","family":"Ugurlu","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Hacettepe University Medical Faculty, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umit Yavuz","family":"Malkan","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Hacettepe University Medical Faculty, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"e_1_3_4_2_2","first-page":"83","article-title":"Dasatinib. Recent results","volume":"184","author":"Lindauer M","year":"2010","unstructured":"Lindauer M, Hochhaus A. Dasatinib. Recent results. Cancer Res 2010; 184: 83\u2013102.","journal-title":"Cancer Res"},{"issue":"2","key":"e_1_3_4_3_2","article-title":"Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer: part II. Targeted therapy","volume":"71","author":"Reyes-Habito CM","year":"2014","unstructured":"Reyes-Habito CM, Roh EK. Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer: part II. Targeted therapy. J Am Acad Dermatol 2014; 71(2): 217.e1\u2013217.e11; quiz 27\u201328.","journal-title":"J Am Acad Dermatol"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14314"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2024.09.027"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15818"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2010.01360.x"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1159\/000494611"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.12.019"}],"container-title":["Sage Open Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2050313X251330969","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2050313X251330969","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2050313X251330969","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:18:50Z","timestamp":1767676730000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2050313X251330969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":9,"alternative-id":["10.1177\/2050313X251330969"],"URL":"https:\/\/doi.org\/10.1177\/2050313x251330969","relation":{},"ISSN":["2050-313X","2050-313X"],"issn-type":[{"value":"2050-313X","type":"print"},{"value":"2050-313X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"article-number":"2050313X251330969"}}